Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 8 of 8 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
NR3C1
💬1. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Betamethasone
Betamethasone
💬1. NR3C1
| Betamethasone | [8] 2 2, 28, 46, 65, 83, 90, 96, 235 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
NR3C1
💬2. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone
Dexamethasone
💬2. NR3C1
| Dexamethasone | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 [22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299💬 ... 2. NR3C1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
PTH1R
💬3. PTH1R
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption [3] Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, En ... | Parathyroid hormone
Parathyroid hormone
💬3. PTH1R
| Parathyroid hormone | [4] 65 65, 70, 235, 326 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
PTH1R
💬4. PTH1R
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption [3] Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, En ... | Teriparatide
Teriparatide
💬4. PTH1R
| Teriparatide | [7] 46 46, 65, 68, 70, 71, 235, 274 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
PTH2R
💬5. PTH2R
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Parathyroid hormone
Parathyroid hormone
💬5. PTH2R
| Parathyroid hormone | [4] 65 65, 70, 235, 326 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
SLC12A3
💬6. SLC12A3
| - | Hydrochlorothiazide
Hydrochlorothiazide
💬6. SLC12A3
| Hydrochlorothiazide | [4] 13 13, 67, 225, 235 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
VDR
💬7. VDR
| [5] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation [5] Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calciu ... | Calcitriol
Calcitriol
💬7. VDR
| Calcitriol | [9] 18 18, 37, 46, 49, 66, 96, 158, 235, 326 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
VDR
💬8. VDR
| [5] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation [5] Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calciu ... | Alfacalcidol
Alfacalcidol
💬8. VDR
| Alfacalcidol | [8] 41 41, 46, 49, 50, 96, 107, 235, 238 💬
|